EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION

This invention provides with an edaravone suspension for oral administration having excellent bioavailability. It is expected that burden on ALS patients and care workers can be reduced thereby.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TAKAHASHI, TOMOHIRO, MIYAZAWA, TADASHI, MATSUDA, MUNETOMO, OMURA, TOMOYUKI, HAYAMA, TETSUO, HAYASHI, KOUJI
Format: Patent
Sprache:eng ; pol
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator TAKAHASHI, TOMOHIRO
MIYAZAWA, TADASHI
MATSUDA, MUNETOMO
OMURA, TOMOYUKI
HAYAMA, TETSUO
HAYASHI, KOUJI
description This invention provides with an edaravone suspension for oral administration having excellent bioavailability. It is expected that burden on ALS patients and care workers can be reduced thereby.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL3875085TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL3875085TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL3875085TT33</originalsourceid><addsrcrecordid>eNrjZNBxdXEMcgzz93NVCA4NDnD1C_b091Nw8w9S8A9y9FFwdPH19PMMDglyDAGK8zCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSS-AAfYwtzUwML05AQY2Ni1AAAxeUmDA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION</title><source>esp@cenet</source><creator>TAKAHASHI, TOMOHIRO ; MIYAZAWA, TADASHI ; MATSUDA, MUNETOMO ; OMURA, TOMOYUKI ; HAYAMA, TETSUO ; HAYASHI, KOUJI</creator><creatorcontrib>TAKAHASHI, TOMOHIRO ; MIYAZAWA, TADASHI ; MATSUDA, MUNETOMO ; OMURA, TOMOYUKI ; HAYAMA, TETSUO ; HAYASHI, KOUJI</creatorcontrib><description>This invention provides with an edaravone suspension for oral administration having excellent bioavailability. It is expected that burden on ALS patients and care workers can be reduced thereby.</description><language>eng ; pol</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241021&amp;DB=EPODOC&amp;CC=PL&amp;NR=3875085T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241021&amp;DB=EPODOC&amp;CC=PL&amp;NR=3875085T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TAKAHASHI, TOMOHIRO</creatorcontrib><creatorcontrib>MIYAZAWA, TADASHI</creatorcontrib><creatorcontrib>MATSUDA, MUNETOMO</creatorcontrib><creatorcontrib>OMURA, TOMOYUKI</creatorcontrib><creatorcontrib>HAYAMA, TETSUO</creatorcontrib><creatorcontrib>HAYASHI, KOUJI</creatorcontrib><title>EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION</title><description>This invention provides with an edaravone suspension for oral administration having excellent bioavailability. It is expected that burden on ALS patients and care workers can be reduced thereby.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBxdXEMcgzz93NVCA4NDnD1C_b091Nw8w9S8A9y9FFwdPH19PMMDglyDAGK8zCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSS-AAfYwtzUwML05AQY2Ni1AAAxeUmDA</recordid><startdate>20241021</startdate><enddate>20241021</enddate><creator>TAKAHASHI, TOMOHIRO</creator><creator>MIYAZAWA, TADASHI</creator><creator>MATSUDA, MUNETOMO</creator><creator>OMURA, TOMOYUKI</creator><creator>HAYAMA, TETSUO</creator><creator>HAYASHI, KOUJI</creator><scope>EVB</scope></search><sort><creationdate>20241021</creationdate><title>EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION</title><author>TAKAHASHI, TOMOHIRO ; MIYAZAWA, TADASHI ; MATSUDA, MUNETOMO ; OMURA, TOMOYUKI ; HAYAMA, TETSUO ; HAYASHI, KOUJI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL3875085TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TAKAHASHI, TOMOHIRO</creatorcontrib><creatorcontrib>MIYAZAWA, TADASHI</creatorcontrib><creatorcontrib>MATSUDA, MUNETOMO</creatorcontrib><creatorcontrib>OMURA, TOMOYUKI</creatorcontrib><creatorcontrib>HAYAMA, TETSUO</creatorcontrib><creatorcontrib>HAYASHI, KOUJI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TAKAHASHI, TOMOHIRO</au><au>MIYAZAWA, TADASHI</au><au>MATSUDA, MUNETOMO</au><au>OMURA, TOMOYUKI</au><au>HAYAMA, TETSUO</au><au>HAYASHI, KOUJI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION</title><date>2024-10-21</date><risdate>2024</risdate><abstract>This invention provides with an edaravone suspension for oral administration having excellent bioavailability. It is expected that burden on ALS patients and care workers can be reduced thereby.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; pol
recordid cdi_epo_espacenet_PL3875085TT3
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T01%3A22%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TAKAHASHI,%20TOMOHIRO&rft.date=2024-10-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL3875085TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true